INFI Archives - Blue Horseshoe Stocks

Monday’s Runners, 4 Fresh Earnings Plays

Good Start to the Trading Week:

We got things off on a decent foot for the week yesterday morning. There weren’t a heck of a lot of earnings reporters off of which to base our daily options targets, but we managed to zero in on a pair of potential plays in our premarket report. It was a special day for us, as we celebrated the 12 year anniversary of our online archives at BlueHorseshoeStocks.com. If you missed our message to our readers, take a second to go check it out!

As for our fresh ideas to kick off the week, we were looking at the BNTX 08/18 $100-95 Puts, and the TSN Weekly $53-52 Puts, and here are the biggest upswings they registered for the session:

BNTX 08/18 $100-95 Puts
$100: 2.50-5.30 (+112%)
$95: .50-2.15 (+330%)
_____

TSN Weekly $53-52 Puts
$53: .60-.77 (+28%)
$52.50: .39-.50 (+28%)
$52: .92-1.37 (+49%)

Fresh Options Ideas:
DDOG Weekly $88-85 Puts
UPS Weekly $175-172.50 Calls
LLY Weekly $490-500 Calls
IFF 08/18 $65-60 Puts

Extended Watchlist:
VVOS, BURU, INFI, DRUG, NVAX, MNPR, NFTG, GRRR, NVO

Earnings Fuel Options Runners

Earnings Plays Paying Off:

We entered a nice mix of options plays both bearish and bullish in our report yesterday morning based on earnings. We were targeting contracts in the TSLA, GE, and RTX chains, specifically the UPS Weekly $210-205 Puts, the GE Weekly $12.50-13 Calls, and the RTX Weekly $86.50-87.50 Calls.

Those targets recorded some very respectable moves on the day, with a fair few breaking into double-bag territory. We can’t always guarantee that our daily ideas will bear fruit, but it’s always nice when we score a 100% success rate. For our newer readers, this actually happens with a frequency that we’re very proud of, and believe you will be impressed with!

Here were the intraday ranges and total possible gains in those plays:

UPS Weekly $210-205 Puts
$210: 12.70-19.55 (+50%)
$207.50: 11.01-16.79 (+51%)
$205: 8.45-14.79 (+54%)
_____

GE Weekly $12.50-13 Calls
$12.50: .42-.71 (+356%)
$13: .14-.31 (+137%)
_____

RTX Weekly $86.50-87.50 Calls
$86.50: 1.51-2.87 (+51%)
$87: 1.24-2.55 (+54%)
$87.50: .91-2.14 (+51%)
_____

More Post-Earnings Options Ideas:
BA Weekly $230-235 Calls
AMD Weekly $92.50-93.50 Calls
SBUX Weekly $124-122 Puts
MSFT Weekly $287.50-292.50 Calls

Probability Media Corp. PBYA – Recap:

We’d also like to recap the performance of an OTC play we’ve been tracking this month. We tagged PBYA in yesterday morning’s extended watchlist and the stock ran for a respectable 56% from .0085-.0133.

For anyone who caught our earlier alert on this play a few weeks ago on the 7th, subsequent to which time it was trading for as little as .0035, yesterday’s high represented an overall move of 280%

Extended Watchlist:
BTBT, INFI, GRVI, SPRT, BOTY, TXTM, CPSL, NHYF, CMFO, DPLS, RSHN, SEEK

Blue Horseshoe Stocks: Fresh Options Idea & More

Campbell Soup Co. CPB – Options Update

We opened up the week yesterday with a fresh options idea, designating the CPB Weekly $30.50-$42 Calls for observation, and we were pleased to be met with potential gains across the board. While not every contract set was a huge runner, they all made gains, including 4 out of 6 recording multi-bag performances on the day.

$30.50 Calls – Range: 2.26-3.12 – Max Gain: 38%
$40 Calls – Range: 1.00-3.00 – Max Gain: 200%
$40.50 Calls – Range: 1.63-2.00 – Max Gain: 23%
$41 Calls – Range: .95-2.10 – Max Gain: 121%
$41.50 Calls – Range: .80-1.80 – Max Gain: 125%
$42 Calls – Range: .60-1.50 – Max Gain: 150%

With the way CPB stock itself behaved, we’ll be very interested to continue to keep an eye on the activity in these plays as the week progresses.

Fresh Options Idea – Harley-Davidson, Inc. HOG

As promised, we also have another fresh options idea today. Harley announced plans to shift some of its US production overseas to avoid EU tariffs over the weekend, and was promptly slammed by Donald Trump.

This has caused a clear over-reaction by enough traders/investors as well as a spike in short interest which is driving the stock down rapidly. It is approaching a multi-bottom setup on the chart, and we’re going to want to be ready to take advantage when the rebound occurs.

We’re going to signal the HOG 08/03 $43-44 Calls, and remain watchful over HOG in the days and weeks ahead for a rebound that could be coming at any time.

Extended Watchlist:
AVGR, GE, GWPH, IIIV, INFI

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.

PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.

AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday.

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.

Extended Watchlist:
AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,

Blue Horseshoe Stocks: INFI Review & More

Infinity Pharmaceuticals, Inc. INFI

The stock with the most notable performance from yesterday morning’s watchlist was definitely INFI, which began trending up in the premarket, and continued its climb throughout the entire session.

The stock traded up from a low of 2.44 to 3.75, which works out to an intraday rise of 54% and it came on roughly 38X its monthly average volume. An early pullback from profit taking this morning would be a likely scenario, but if INFI can find support at a higher point than yesterday’s low, from

AcelRx Pharmaceuticals, Inc. ACRX

After the FDA’s rejecion of the company’s ‘Dsuvia” opioid painkiller, ACRX took a monstrous pounding yesterday down to its lowest price in three months.

As you can see on the chart, it fell all the way down to an area of support it had established back in July. We’ll be interested to monitor this play for a bottom, which could come at any time. Moves generated by FDA news, whether positive or negative, tend to be over-exaggerated and are almost always followed by a course correction.

Inotek Pharmaceuticals Corp ITEK

Here we have an example of being extremely ‘early to the party’ as we sometimes say. We alerted on ITEK back in July, after which point it saw a low of .89. It mostly traded sideways throughout the remainder of the summer, but recently began quite an impressive climb.

This morning, the stock hit news highs of 4.15 in premarket trading on news of a proposed merger with a clinical stage gene therapy company. It may have took a few months to realize, but it works out to an increase of 366%

For an added angle going forward, we’ll also signal the ITEK 10/20 $2.50 Calls for possible daytrades and/or swing trades into next week, and the 11/17 $2.50 & $5.00 Calls for a longer term idea.

Extended Watchlist:
SONS, MARK, HSC, DPW, AKS, CLF, RIG, ATNM, MGEN